IP Library Granted Patent US 8,314,064
Granted Patent B2
US 8,314,064 · App. 10/972,777 · Granted Nov 20, 2012

Uridine administration stimulates membrane production

Assignee: Massachusetts Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,314,064
App. No.
10/972,777
Granted
Nov 20, 2012
Kind
B2
Abstract

The present invention provides methods of stimulating or enhancing production of a cellular membrane, improving a cognitive function or a neurological function, treating or ameliorating a decline in a cognitive function or a neurological function, increasing cytidine levels, or treating a neurological disorder in a subject, comprising administering a uridine, a uridine precursor, or a derivative or metabolite thereof to the subject. The invention also provides methods of improving neural function, comprising contacting the neuron with a uridine, a uridine precursor, or a derivative or metabolite thereof.

Claims (10)

1. A method of stimulating or enhancing the production of a membrane of a brain cell or a neural cell of a subject in need thereof in the presence of NGF comprising administering to said subject between about 20 mg and about 0.75 g per day of uridine or of a uridine phosphate.

2. The method of claim 1 , wherein said brain cell is newly differentiated.

3. The method of claim 1 , wherein said membrane is a dendritic membrane.

4. The method of claim 1 , wherein said membrane is an axonal membrane.

5. A method of stimulating or enhancing the production of a membrane of a brain cell or a neural cell in need thereof in the presence of NGF comprising contacting said brain cell with between about 20 mg and about 0.75 g per day of uridine or of a uridine phosphate.

6. The method of claim 5 , wherein said brain cell is newly differentiated.

7. The method of claim 5 , wherein said membrane is a dendritic membrane.

8. The method of claim 5 , wherein said membrane is an axonal membrane.

9. The method of claim 1 , wherein said uridine phosphate is uridine-5′-monophosphate (UMP), uridine-5′-diphosphate (UDP), uridine-5′-triphosphate (UTP), or is a salt of said UMP, UDP, or UTP.

10. The method of claim 5 , wherein said uridine phosphate is uridine-5′-monophosphate (UMP), uridine-5′-diphosphate (UDP), uridine-5′-triphosphate (UTP), or is a salt of said UMP, UDP, or UTP.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 2, 2011
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025882/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2005
From: WURTMAN, DICK; WATKINS, CAROL
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 016497/0274 →
Continuity (4)
Continuation In Part 10941025 · Sep 15, 2004
Continuation In Part 09363748 · Jul 30, 1999
Provisional Application 60095002 · Jul 31, 1998
Related Publication 20050176676A1 · Aug 11, 2005